NCT01249105 2016-03-10MK-2206 for Recurrent Malignant GliomaDana-Farber Cancer InstitutePhase 2 Withdrawn
NCT01240941 2013-08-20Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast CancerVanderbilt-Ingram Cancer CenterPhase 2 Withdrawn